| Target- | 
| Mechanism- | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.Japan | 
| First Approval Date18 May 1991 | 
100 Clinical Results associated with Nikko Co., Ltd. (6306)
0  Patents (Medical) associated with Nikko Co., Ltd. (6306)
100 Deals associated with Nikko Co., Ltd. (6306)
100 Translational Medicine associated with Nikko Co., Ltd. (6306)